Elon Musk’s Neuralink Says Brain-to-Computer Interface Has FDA Approval for Clinical Trial
FRIDAY, May 26, 2023 (HealthDay News) — It may sound like the stuff of science fiction, but Elon Musk’s company Neuralink announced Thursday that the U.S. Food and Drug Administration has approved a human clinical trial of a device that may restore or enhance function when implanted in a humanContinue Reading